Skip to content

Study · Ex vivo tissue · 1985

1 result

T-cell abnormalities after mediastinal irradiation for lung cancer. The in vitro influence of synthetic thymosin alpha-1.

Schulof RS, Chorba TL, Cleary PA, Palaszynski SR, Alabaster O, Goldstein AL

Cancer1 Mar 1985Cited by 17 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01LabEx vivo tissueEfficacy outcome

    In T-cells from patients with post-irradiation abnormalities, short-term in vitro incubation with thymosin alpha‑1 enhanced the mixed lymphocyte response in 12 of 27 patients.

    In plain wordsIn lab tests on T-cells taken after chest radiotherapy for lung cancer, thymosin alpha‑1 improved the cell response in 12 of 27 samples.

    Outcome
    IncreaseMixed lymphocyte culture response after in vitro incubation
    Study

    humann = 27

    T-cells from patients with non-small cell lung cancer after mediastinal irradiation
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Measurements

    patients with enhanced MLR
    12 patients
    of 27 with post-RT abnormalities

    Source sentences

    Summary
    A short-term in vitro incubation with thymosin alpha-1 could enhance MLR of T-cells in 12 of 27 patients with post-RT abnormalities.
    1 context sentence
    Summary · context
    The effects of mediastinal irradiation (RT) on the numbers and functions of purified peripheral blood T-lymphocytes from patients with locally advanced non-small cell lung cancer were evaluated.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:55 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.